The oral administration of SPS did not have any hepatotoxic effects, and the SPS treatment resulted in decreased serum levels of GPT/ALT and GOT/AST in SI-AD mice (p < 0.05) (Table 2). This evidence concerns the gene GPT and Alzheimer disease.